9 results  1 of 1 

1 Pulmonary Hypertension in Patient with Neurofibromatosis Type 1
Yeong min Lee, Tae Hyun Yang, HeeSoo Jung, Tae-Seon Oh, Jeong-Hoon Song, Seung-Jung Yu
Kosin Med J.2017;32(2):227-232.   Published online 2017 December 29     DOI: http://dx.doi.org/10.7180/kmj.2017.32.2.227
      
2 Successful Treatment of Newly Developed, Intractable Digital Ulcers and Gangrene with Bosentan in Systemic Sclerosis
Hee-Sang Tag, Sung-Min Jun, Seung Geun Lee, Eun Kyoung Park, Dong-Wan Koo, Geun Tae Kim
J Rheum Dis.2016;23(3):193-197.   Published online 2016 October 31     DOI: http://dx.doi.org/10.4078/jrd.2016.23.3.193
   
3 The Effect of Nonspecific Endothelin-1 Receptor Blocker (Bosentan®) on Paraquat Induced Pulmonary Fibrosis in Rat
Hye Cheol Jeong, Ki Hwan Jung, Byung Gyu Kim, Seung Heon Lee, Min Kyung Kim, Chung Yeul Kim, Sang Myung Park, Sin Hyung Lee, Chol Shin, Jae Youn Cho, Se Hwa Yoo, Kyung Ho Kang
Tuberc Respir Dis.2001;50(2):182-195.   Published online 2016 March 9     DOI: http://dx.doi.org/10.4046/trd.2001.50.2.182
      
4 Apoptosis and Inflammation Associated Gene Expressions in Monocrotaline-Induced Pulmonary Hypertensive Rats after Bosentan Treatment
Young Mi Hong, Jung Hyun Kwon, Shinkyu Choi, Kwan Chang Kim
Korean Circ J.2014;44(2):97-104.   Published online 2014 March 12     DOI: http://dx.doi.org/10.4070/kcj.2014.44.2.97
      
5 Transient Use of Oral Bosentan Can Be an Additional Option to Reduce Pulmonary Arterial Hypertension in a Patient with Severe Pulmonary Arterial Hypertension Associated with Atrial Septal Defect
Yong Kyu Park, Jae-Hyeong Park, Jae Hyeon Yu, Jun Hyung Kim, Jae-Hwan Lee, Si Wan Choi, Jin-Ok Jeong, In-Whan Seong
J Cardiovasc Ultrasound.2011;19(3):159-162.   Published online 2011 September 30     DOI: http://dx.doi.org/10.4250/jcu.2011.19.3.159
      
6 Effects of Bosentan Treatment on Angiotensin Converting Enzyme in Monocrotaline Induced Pulmonary Hypertension Rats
Sung Jin Kim, Ji Hae Cha, Hae Ryun Lee, Young Mi Hong
J Korean Soc Hypertens.2011;17(1):28-36.   Published online 2011 March 10     DOI: http://dx.doi.org/10.5646/jksh.2011.17.1.28
   
7 Gene Expression of Endothelin-1 and Endothelin Receptor A on Monocrotaline-Induced Pulmonary Hypertension in Rats After Bosentan Treatment
Kyoung Ah Lim, Kwan Chang Kim, Min-Sun Cho, Bo En Lee, Hae Soon Kim, Young Mi Hong
Korean Circ J.2010;40(9):459-464.   Published online 2010 September 30     DOI: http://dx.doi.org/10.4070/kcj.2010.40.9.459
      
8 Beneficial and Adverse Effects of Bosentan Treatment in Korean Patients With Pulmonary Artery Hypertension
Dae-Won Sohn, Hyung-Kwan Kim, Myung-A Kim, Yeong-Wook Song, Chung-Il Noh, Duk-Kyung Kim, I-Seok Kang, Hojoong Kim, Sang-Do Lee, Young-Hwue Kim, Ho-Joong Youn, Namsik Chung, Jae-Young Choi, Jae-Bum Jun, Jinho Shin
Korean Circ J.2009;39(3):105-110.   Published online 2009 March 25     DOI: http://dx.doi.org/10.4070/kcj.2009.39.3.105
      
9 Effect of Endothelin Antagonists on Myocardial Infarct Size after Coronary Artery Occlusion and Reperfusion in Rat
Bonggwan Seo, Jin-Yong Hwang
Korean Circ J.1997;27(11):1190-1198.   Published online 1997 November 30     DOI: http://dx.doi.org/10.4070/kcj.1997.27.11.1190
      

 1 of 1